These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32216566)

  • 1. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
    Mohamed EM; Younes AH; Hussein GM
    J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
    Chalermchai T; Rummaneethorn P
    J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
    Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients.
    Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C
    J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
    Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melasma: treatment evaluation.
    Salem A; Gamil H; Ramadan A; Harras M; Amer A
    J Cosmet Laser Ther; 2009 Sep; 11(3):146-50. PubMed ID: 19340686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.